Meeder Asset Management Inc Ampio Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 16, 2019	SELL	$0.43 - $0.68 $2,106 - $3,331	-4,899 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$0.39 - $0.7 $1,714 - $3,076	4,395 Added 872.02%	4,899 $2,000
Q3 2018 Nov 02, 2018	BUY	$0.44 - $3.02 $221 - $1,522	504 New	504 $0
Q1 2018 May 03, 2018	SELL	$2.16 - $3.48 $1,010 - $1,628	-468 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$0.68 - $4.19 $1,933 - $11,916	-2,844 Reduced 85.87%	468 $2,000
Q3 2017 Oct 20, 2017	BUY	$0.38 - $0.66 $1,258 - $2,185	3,312	3,312 $2,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.